Lon Hik News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Lon hik. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Lon Hik Today - Breaking & Trending Today

Brokerages Set Hikma Pharmaceuticals PLC (LON:HIK) Price Target at GBX 2,068.75

Shares of Hikma Pharmaceuticals PLC (LON:HIK – Get Free Report) have earned an average rating of “Moderate Buy” from the six brokerages that are covering the company, Marketbeat reports. Three investment analysts have rated the stock with a hold recommendation and three have given a buy recommendation to the company. The average twelve-month price objective […] ....

Hikma Pharmaceuticals , Analyst Recommendations For Hikma Pharmaceuticals , Berenberg Bank , News Ratings For Hikma Pharmaceuticals Daily , Hikma Pharmaceuticals Increases Dividend , Hikma Pharmaceuticals Stock Performance , Get Free Report , Get Free , Hikma Pharmaceuticals Daily , Lon Hik ,

Hikma Pharmaceuticals PLC (LON:HIK) Receives Consensus Recommendation of "Moderate Buy" from Analysts

Shares of Hikma Pharmaceuticals PLC (LON:HIK – Get Free Report) have been assigned an average rating of “Moderate Buy” from the six analysts that are currently covering the firm, MarketBeat reports. Three investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. The average 12 […] ....

United States , Hikma Pharmaceuticals Increases Dividend , Hikma Pharmaceuticals Company Profile , Hikma Pharmaceuticals Stock Performance , Hikma Pharmaceuticals , Analyst Recommendations For Hikma Pharmaceuticals , Berenberg Bank , News Ratings For Hikma Pharmaceuticals Daily , Get Free Report , Get Free , North America , Middle East , North Africa , Hikma Pharmaceuticals Daily , Lon Hik ,

Hikma Pharmaceuticals (LON:HIK) Price Target Increased to GBX 2,000 by Analysts at Berenberg Bank

Hikma Pharmaceuticals (LON:HIK – Free Report) had its target price increased by Berenberg Bank from GBX 1,960 ($24.86) to GBX 2,000 ($25.37) in a research report released on Monday, Digital Look reports. The firm currently has a hold rating on the stock. Separately, Royal Bank of Canada restated a sector perform rating and issued a […] ....

United States , Hikma Pharmaceuticals Stock Performance , News Ratings For Hikma Pharmaceuticals Daily , Hikma Pharmaceuticals Company Profile , Berenberg Bank , Hikma Pharmaceuticals Increases Dividend , Royal Bank , Analyst Recommendations For Hikma Pharmaceuticals , Hikma Pharmaceuticals , Free Report , Digital Look , Moderate Buy , Get Free Report , North America , Middle East , North Africa , Hikma Pharmaceuticals Daily , Lon Hik , Boost Price Target ,

Hikma Pharmaceuticals PLC (LON:HIK) Receives Average Rating of "Moderate Buy" from Brokerages

Hikma Pharmaceuticals PLC (LON:HIK – Get Free Report) has received a consensus rating of “Moderate Buy” from the six analysts that are currently covering the stock, Marketbeat Ratings reports. Three research analysts have rated the stock with a hold rating and three have issued a buy rating on the company. The average 12-month price target […] ....

United States , Hikma Pharmaceuticals , Royal Bank , Hikma Pharmaceuticals Stock Performance , Jpmorgan Chase Co , News Ratings For Hikma Pharmaceuticals Daily , Hikma Pharmaceuticals Company Profile , Analyst Recommendations For Hikma Pharmaceuticals , Get Free Report , Marketbeat Ratings , Get Free , North America , Middle East , North Africa , Hikma Pharmaceuticals Daily , Lon Hik ,

Hikma Pharmaceuticals' (HIK) "Overweight" Rating Reaffirmed at JPMorgan Chase & Co.

JPMorgan Chase & Co. reiterated their overweight rating on shares of Hikma Pharmaceuticals (LON:HIK – Free Report) in a research report report published on Monday morning, MarketBeat reports. Other equities research analysts have also recently issued reports about the company. Barclays lifted their price objective on Hikma Pharmaceuticals from GBX 1,700 ($20.76) to GBX 1,800 […] ....

United States , Hikma Pharmaceuticals Company Profile , Jpmorgan Chase Co , Analyst Recommendations For Hikma Pharmaceuticals , Hikma Pharmaceuticals , News Ratings For Hikma Pharmaceuticals Daily , Hikma Pharmaceuticals Price Performance , Hikma Pharmaceuticals Cuts Dividend , Free Report , Moderate Buy , Get Free Report , North America , Middle East , North Africa , Hikma Pharmaceuticals Daily , Lon Hik , Reiterated Rating , Jpmorgan Chase Co ,